These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25527759)

  • 1. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
    Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
    Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
    Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.
    Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X
    Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study.
    Lemaitre RN; Fretts AM; Sitlani CM; Biggs ML; Mukamal K; King IB; Song X; Djoussé L; Siscovick DS; McKnight B; Sotoodehnia N; Kizer JR; Mozaffarian D
    Am J Clin Nutr; 2015 May; 101(5):1047-54. PubMed ID: 25787996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
    Wu JH; Lemaitre RN; Manichaikul A; Guan W; Tanaka T; Foy M; Kabagambe EK; Djousse L; Siscovick D; Fretts AM; Johnson C; King IB; Psaty BM; McKnight B; Rich SS; Chen YD; Nettleton JA; Tang W; Bandinelli S; Jacobs DR; Browning BL; Laurie CC; Gu X; Tsai MY; Steffen LM; Ferrucci L; Fornage M; Mozaffarian D
    Circ Cardiovasc Genet; 2013 Apr; 6(2):171-83. PubMed ID: 23362303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
    Qureshi W; Santaren ID; Hanley AJ; Watkins SM; Lorenzo C; Wagenknecht LE
    BMJ Open Diabetes Res Care; 2019; 7(1):e000691. PubMed ID: 31543975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
    Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.
    Forouhi NG; Koulman A; Sharp SJ; Imamura F; Kröger J; Schulze MB; Crowe FL; Huerta JM; Guevara M; Beulens JW; van Woudenbergh GJ; Wang L; Summerhill K; Griffin JL; Feskens EJ; Amiano P; Boeing H; Clavel-Chapelon F; Dartois L; Fagherazzi G; Franks PW; Gonzalez C; Jakobsen MU; Kaaks R; Key TJ; Khaw KT; Kühn T; Mattiello A; Nilsson PM; Overvad K; Pala V; Palli D; Quirós JR; Rolandsson O; Roswall N; Sacerdote C; Sánchez MJ; Slimani N; Spijkerman AM; Tjonneland A; Tormo MJ; Tumino R; van der A DL; van der Schouw YT; Langenberg C; Riboli E; Wareham NJ
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):810-8. PubMed ID: 25107467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte Saturated Fatty Acids and Incident Type 2 Diabetes in Chinese Men and Women: A Prospective Cohort Study.
    Lin JS; Dong HL; Chen GD; Chen ZY; Dong XW; Zheng JS; Chen YM
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30275386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort.
    Zhu Y; Vogelpohl FA; Heiner-Fokkema MR; Pranger IG; Minović I; Navis GJ; Bakker SJL; Riphagen IJ
    J Clin Lipidol; 2022; 16(5):658-666. PubMed ID: 35909048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
    Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
    PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study.
    Fretts AM; Mozaffarian D; Siscovick DS; Djousse L; Heckbert SR; King IB; McKnight B; Sitlani C; Sacks FM; Song X; Sotoodehnia N; Spiegelman D; Wallace ER; Lemaitre RN
    J Am Heart Assoc; 2014 Jun; 3(3):e000889. PubMed ID: 24970268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length.
    Fretts AM; Mozaffarian D; Siscovick DS; King IB; McKnight B; Psaty BM; Rimm EB; Sitlani C; Sacks FM; Song X; Sotoodehnia N; Spiegelman D; Lemaitre RN
    J Nutr; 2016 Feb; 146(2):298-305. PubMed ID: 26701797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study.
    Mozaffarian D; Cao H; King IB; Lemaitre RN; Song X; Siscovick DS; Hotamisligil GS
    Ann Intern Med; 2010 Dec; 153(12):790-9. PubMed ID: 21173413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fatty acids in de novo lipogenesis pathway are associated with diabetogenic indicators among adults: NHANES 2003-2004.
    Yu EA; Hu PJ; Mehta S
    Am J Clin Nutr; 2018 Sep; 108(3):622-632. PubMed ID: 30535092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Weir NL; Steffen BT; Guan W; Johnson LM; Djousse L; Mukamal KJ; Tsai MY
    Diabetes Metab; 2020 Sep; 46(4):319-325. PubMed ID: 31706030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study.
    Imamura F; Sharp SJ; Koulman A; Schulze MB; Kröger J; Griffin JL; Huerta JM; Guevara M; Sluijs I; Agudo A; Ardanaz E; Balkau B; Boeing H; Chajes V; Dahm CC; Dow C; Fagherazzi G; Feskens EJM; Franks PW; Gavrila D; Gunter M; Kaaks R; Key TJ; Khaw KT; Kühn T; Melander O; Molina-Portillo E; Nilsson PM; Olsen A; Overvad K; Palli D; Panico S; Rolandsson O; Sieri S; Sacerdote C; Slimani N; Spijkerman AMW; Tjønneland A; Tumino R; van der Schouw YT; Langenberg C; Riboli E; Forouhi NG; Wareham NJ
    PLoS Med; 2017 Oct; 14(10):e1002409. PubMed ID: 29020051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte saturated fatty acids and systemic inflammation in adults.
    Mu L; Mukamal KJ; Naqvi AZ
    Nutrition; 2014; 30(11-12):1404-8. PubMed ID: 25280420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.